D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 72 Citations 18,095 148 World Ranking 3945 National Ranking 288

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Enzyme

His scientific interests lie mostly in Immunology, Molecular biology, Cell biology, Monoclonal antibody and Fas ligand. His Immunology study integrates concerns from other disciplines, such as Peripheral blood mononuclear cell, Gene signature and Lung. His Molecular biology study combines topics in areas such as Receptor, Signal transduction, MHC class II and Follicular dendritic cells.

He interconnects Endothelium, Immune system and Monocyte in the investigation of issues within Cell biology. His Monoclonal antibody study results in a more complete grasp of Antibody. His study in Antibody is interdisciplinary in nature, drawing from both Palivizumab, Virus and Virology.

His most cited work include:

  • Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. (1074 citations)
  • Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. (528 citations)
  • Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn) (527 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Immunology, Antibody, Molecular biology, Monoclonal antibody and Cell biology. The Immunology study which covers Disease that intersects with Pathogenesis. His Antibody research is multidisciplinary, incorporating perspectives in Antigen and Virology.

His Molecular biology study incorporates themes from Cell, Cytotoxic T cell, CD40, T cell and Receptor. His Cell biology research incorporates themes from Fas ligand, Apoptosis, Immune system and Monocyte. Peter A. Kiener focuses mostly in the field of Cytokine, narrowing it down to topics relating to Proinflammatory cytokine and, in certain cases, Fas receptor.

He most often published in these fields:

  • Immunology (31.07%)
  • Antibody (27.12%)
  • Molecular biology (26.55%)

What were the highlights of his more recent work (between 2009-2020)?

  • Immunology (31.07%)
  • Antibody (27.12%)
  • Molecular biology (26.55%)

In recent papers he was focusing on the following fields of study:

Peter A. Kiener mainly focuses on Immunology, Antibody, Molecular biology, Monoclonal antibody and Virology. The various areas that Peter A. Kiener examines in his Immunology study include Dermatomyositis and Lung. His research integrates issues of Stereochemistry and Ligand in his study of Antibody.

Peter A. Kiener has researched Molecular biology in several fields, including Mole, ISG15, Interferon α and Antigen. His Monoclonal antibody research integrates issues from Nucleic acid, Expression vector and Gene isoform. His Cytokine research is multidisciplinary, relying on both Proinflammatory cytokine, Fas receptor, Monocyte-Derived Macrophages and Tumor necrosis factor alpha.

Between 2009 and 2020, his most popular works were:

  • MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function. (352 citations)
  • Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor α antibody, in a phase I study of subjects with mild asthma (253 citations)
  • Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway (222 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Enzyme

His main research concerns Immunology, Antibody-dependent cell-mediated cytotoxicity, Antibody, CD19 and Molecular biology. His research in the fields of Polymyositis, Cytokine and Eosinophil cationic protein overlaps with other disciplines such as Reslizumab. The Polymyositis study combines topics in areas such as Tumor necrosis factor alpha, Longitudinal study, Gene expression, Gene expression profiling and Signal transduction.

His Cytokine study combines topics from a wide range of disciplines, such as Pathogenesis, Inflammation, Allergic inflammation, Ovalbumin and Lung. In his study, which falls under the umbrella issue of Antibody-dependent cell-mediated cytotoxicity, Eosinophil-derived neurotoxin, Interleukin 5 and Basophil is strongly linked to Peripheral blood mononuclear cell. His research in Antibody intersects with topics in Cluster of differentiation and Antigen.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE.

Jane Tian;Ana Maria Avalos;Su-Yau Mao;Bo Chen.
Nature Immunology (2007)

1510 Citations

Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)

William F. Dall'Acqua;Peter A. Kiener;Herren Wu.
Journal of Biological Chemistry (2006)

721 Citations

Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils.

W C Liles;P A Kiener;J A Ledbetter;A Aruffo.
Journal of Experimental Medicine (1996)

690 Citations

A Chitinase-like Protein in the Lung and Circulation of Patients with Severe Asthma

Geoffrey L Chupp;Chun Geun Lee;Nizar Jarjour;Yun Michael Shim.
The New England Journal of Medicine (2007)

625 Citations

MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function.

Roland Kolbeck;Alexander Kozhich;Masamichi Koike;Li Peng.
The Journal of Allergy and Clinical Immunology (2010)

559 Citations

Expression of functional CD40 by vascular endothelial cells.

Diane Hollenbaugh;Nicole Mischel-Petty;Caroline P. Edwards;Jan C. Simon.
Journal of Experimental Medicine (1995)

559 Citations

Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes

P A Kiener;P Moran-Davis;B M Rankin;A F Wahl.
Journal of Immunology (1995)

481 Citations

Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract.

Herren Wu;David S. Pfarr;Syd Johnson;Yambasu A. Brewah.
Journal of Molecular Biology (2007)

472 Citations

Increasing the Affinity of a Human IgG1 for the Neonatal Fc Receptor: Biological Consequences

William F. Dall’ Acqua;Robert M. Woods;E. Sally Ward;Susan R. Palaszynski.
Journal of Immunology (2002)

439 Citations

Soluble Fas Ligand Induces Epithelial Cell Apoptosis in Humans with Acute Lung Injury (ARDS)

G Matute-Bello;W C Liles;K P Steinberg;P A Kiener.
Journal of Immunology (1999)

399 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Peter A. Kiener

Herren Wu

Herren Wu

AstraZeneca (United Kingdom)

Publications: 71

David S. Pisetsky

David S. Pisetsky

Duke University

Publications: 48

John R. Desjarlais

John R. Desjarlais

Pennsylvania State University

Publications: 41

Alexis M. Kalergis

Alexis M. Kalergis

Pontificia Universidad Católica de Chile

Publications: 33

H. Joachim Deeg

H. Joachim Deeg

Fred Hutchinson Cancer Research Center

Publications: 33

Haichao Wang

Haichao Wang

Feinstein Institute for Medical Research

Publications: 32

Thomas R. Martin

Thomas R. Martin

University of Washington

Publications: 31

Anil K. Sood

Anil K. Sood

The University of Texas MD Anderson Cancer Center

Publications: 29

Julia S. Johansen

Julia S. Johansen

Copenhagen University Hospital

Publications: 28

Chun Geun Lee

Chun Geun Lee

Brown University

Publications: 27

Patrick A. Baeuerle

Patrick A. Baeuerle

Cullinan Oncology, Inc.

Publications: 26

Jack A. Elias

Jack A. Elias

Brown University

Publications: 26

John V. Williams

John V. Williams

University of Pittsburgh

Publications: 25

Jason S. McLellan

Jason S. McLellan

The University of Texas at Austin

Publications: 25

Roland Kolbeck

Roland Kolbeck

AstraZeneca (United Kingdom)

Publications: 24

Inger Sandlie

Inger Sandlie

University of Oslo

Publications: 24

Trending Scientists

Wuhua Li

Wuhua Li

Zhejiang University

Carla Caramella

Carla Caramella

University of Pavia

Insung S. Choi

Insung S. Choi

Korea Advanced Institute of Science and Technology

Xinjian Li

Xinjian Li

Zhengzhou University

Craig H. Bassing

Craig H. Bassing

Children's Hospital of Philadelphia

Elena Zocchi

Elena Zocchi

University of Genoa

Akio Suzumura

Akio Suzumura

Nagoya University

Toshio Takeuchi

Toshio Takeuchi

Tokyo University of Marine Science and Technology

Kanefusa Kato

Kanefusa Kato

Nagoya University

Anders Johansson

Anders Johansson

Umeå University

Jens Greinert

Jens Greinert

GEOMAR Helmholtz Centre for Ocean Research Kiel

Alan K. Betts

Alan K. Betts

Colorado State University

Tobias Kaufmann

Tobias Kaufmann

University of Tübingen

Norbert Graf

Norbert Graf

Saarland University

Mark E. Molitch

Mark E. Molitch

Northwestern University

Something went wrong. Please try again later.